Encapsidated adenovirus minichromosomes allow delivery and expression of a 14 kb dystrophin cDNA to muscle cells

Human Molecular Genetics

Volumn 5, Issue 7, 1996, Pages 913-921

  Kumar Singh, Rajendra ^a   Chamberlain, Jeffrey S ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; CESIUM CHLORIDE; COMPLEMENTARY DNA; DYSTROPHIN; RECOMBINANT DNA; VIRUS DNA;

ADENOVIRUS; ARTICLE; CONTROLLED STUDY; DENSITY GRADIENT CENTRIFUGATION; DNA REPLICATION ORIGIN; ENHANCER REGION; EXPRESSION VECTOR; GENE EXPRESSION; GENE TARGETING; GENE TRANSFER; MINICHROMOSOME; MUSCLE; NONHUMAN; PLASMID; PRIORITY JOURNAL; PROMOTER REGION; REPORTER GENE;

ADENOVIRUSES, HUMAN; ANIMALS; BETA-GALACTOSIDASE; CELL LINE; CHROMOSOMES; DNA, BACTERIAL; DNA, COMPLEMENTARY; DNA, RECOMBINANT; DYSTROPHIN; ENHANCER ELEMENTS (GENETICS); GENE TRANSFER TECHNIQUES; GENES, REPORTER; GENETIC VECTORS; HELPER VIRUSES; HUMANS; MICE; MICE, INBRED MDX; MUSCLE FIBERS; MUSCLES; MUSCULAR DYSTROPHIES; PLASMIDS; PROMOTER REGIONS (GENETICS); REPLICATION ORIGIN; SERIAL PASSAGE; VIRUS ASSEMBLY; VIRUS REPLICATION;

EID: 0030016358     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/5.7.913     Document Type: Article

References (47)

1. Emery, A.E.H. (1993) Duchenne Muscular Dystrophy. Oxford Monographs on Medical Genetics No. 24. Edn 2, Oxford Medical Publications, Oxford,.
2. Ahn, A.H. and Kunkel, L.M. (1993) The structural and functional diversity of dystrophin. Nature Genet., 3, 283-291.
3. Bulfield, G., Siller, W.G., Wight, P.A. and Moore, K.J. (1984) X chromosome-linked muscular dystrophy (mdx) in the mouse. Proc. Natl Acad. Sci. USA, 81, 1189-1192.
4. Sicinski, P., Geng, Y., Ryder-Cook, A.S., Barnard, E.A., Darlison, M.G. and Barnard, P.J. (1989) The molecular basis of muscular dystrophy in the mdx mouse: a point mutation. Science, 244, 1578-1580.
5. Cox, G.A., Cole, N.M., Matsumura, K., Phelps, S.F., Hauschka, S.D., Campbell, K.P., Faulkner, J.A. and Chamberlain, J.S. (1993) Overexpression of dystrophin in transgenic mdx mice eliminates dystrophic symptoms without toxicity. Nature, 364, 725-729.
6. Phelps, S.F., Hauser, M.A., Cole, N.M., Rafael, J.A., Hinkle, R.T., Faulkner, J.A. and Chamberlain, J.S. (1995) Expression of full-length and truncated dystrophin mini-genes in transgenic mdx mice. Ham. Mol. Genet., 4, 1251-1258.
7. Wells, D.J., Wells, K.E., Asante, E.A., Turner, G., Sunada, Y., Campbell, K.P., Walsh, F.S. and Dickson, G. (1995) Expression of human full-length and minidystrophin in transgenic mdx mice: implications for gene therapy of Duchenne muscular dystrophy. Hum. Mol. Genet, 4, 1245-1250.
8. Quantin, B., Perricaudet, L.D., Tajbakhsh, S. and Mandel, J.L. (1992) Adenovirus as an expression vector in muscle cells in viva. Proc. Natl Acad. Sci. USA, 89, 2581-2584.
9. Graham, F.L. and Prevec, L. (1991), Manipulation of adenovirus vectors. In Murray, E.J. (ed.), Methods in Molecular Biology, Vol. 7: Gene Transfer and Expression Protocols. The Humana Press Inc., Clifton, NJ, pp. 109-128.
10. Bett, A.J., Prevec, L. and Graham, F.L. (1993) Packaging capacity and stability of human adenovirus type 5 vectors. J. Virol., 67, 5911-5921.
11. Goldman, M.J., Litzky, L.A., Engelhardt, J.F. and Wilson, J.M. (1995) Transfer of the CFTR gene to the lung of nonhuman primates with E1-deleted, E2a-defective recombinant adenoviruses: a preclinical toxicology study. Hum. Gene Ther., 6, 839-851.
12. Kass-Eisler, A., Falck-Pedersen, E., Elfenbein, D.H., Alvira, M., Buttrick, P.M. and Leinwand, L.A. (1994) The impact of developmental stage, route of administration and the immune system on adenovirus-mediated gene transfer. Gene Therapy, 1, 395-402.
13. Yang, Y., Nunes, F.A., Berencsi, K., Furth, E.E., Gonczol, E. and Wilson, J.M. (1994) Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. Proc. Natl Acad. Sci. USA, 91, 4407-4411.
14. Engelhardt, J.F., Litzky, L. and Wilson, J.M. (1994) Prolonged transgene expression in cotton rat lung with recombinant adenoviruses defective in E2a. Hum. Gene Ther., 5, 1217-1229.
15. Yang, Y., Nunes, F.A., Berencsi, K., Gönczöl, E., Englelhardt, J.F. and Wilson, J.M. (1994) Inactivation of E2a in recombinant adenoviruses improves the prospect for gene therapy in cystic fibrosis. Nature Genet., 7, 362-369.
16. Graham, F.L., Rudy, J. and Brinkley, P. (1989) Infectious circular DNA of human adenovirus type 5: regeneration of viral DNA termini from molecules lacking terminal sequences. EMBO J., 8, 2077-2085.
17. Muller, D.W., Gordon, D., San, H., Yang, Z., Pompili, V.J., Nabel, G.J. and Nabel, E.G. (1994) Catheter-mediated pulmonary vascular gene transfer and expression. Circ. Res., 75, 1039-1049.
18. Daniell, E. (1976) Genome structure of incomplete particles of adenovirus. J. Virol., 19, 685-708.
19. Rosenwirth, B., Tjia, S., Westphal, M. and Doerfler, W. (1974) Incomplete particles of adenovirus. II. Kinetics of formation and polypeptide composition of adenovirus type 2. Virology., 60, 431-437.
20. Burlingham, B.T., Brown, D.T. and Doerfler, W. (1974) Incomplete particles of adenovirus. 1. Characteristics of the DNA associated with incomplete adenovirions of types 2 and 12. Virology, 60, 419-430.
21. Lochmüller, H., Jani, A., Huard, J., Prescott, S., Simoneau, M., Massie, B., Karpati, G. and Acsadi, G. (1994) Emergence of early region 1-containing replication-competent adenovirus in stocks of replication-defective adenovirus recombinants (ΔE1+ΔE3) during multiple passages in 293 cells. Hum. Gene Ther., 5, 1485-1491.
22. Partridge, T.A., Morgan, J.E., Coulton, G.R., Hoffman, E.P. and Kunkel, L.M. (1989) Conversion of mdx myofibres from dystrophin-negative to -positive by injection of normal myoblasts. Nature, 337, 176-179.
23. Acsadi, G., Dickson, G., Love, D.R., Jani, A., Walsh, F.S., Gurusinghe, A., Wolff, J.A. and Davies, K.E. (1991) Human dystrophin expression in mdx mice after intramuscular injection of DNA constructs. Nature, 352, 815-818.
24. Dunckley, M.G., Love, D.R., Davies, K.E., Walsh, F.S., Morris, G.E. and Dickson, G. (1992) Retroviral-mediated transfer of a dystrophin minigene into mdx mouse myoblasts in vitro. FEBS Lett., 296, 128-134.
25. Ragot, T., Vincent, N., Chafey, P., Vigne, E., Gilggenkrantz, H., Couton, D., Cartaud, J., Briand, P., Kaplan, J., Perricaudet, M. and Kahn, A. (1993) Efficient adenovirus-mediated transfer of a human minidystrophin gene to skeletal muscle of mdx mice. Nature, 361, 647-650.
26. Huard, J., Bouchard, J.P., Roy, R., Malouin, F., Dansereau, G., Labrecque, C., Albert, N., Richards, C.L., Lemieux, B. and Tremblay, J.P. (1992) Human myoblast transplantation: preliminary results of 4 cases. Muscle Nerve, 15, 550-560.
27. Gussoni, E., Pavlath, G.K., Lanctot, A.M., Sharma, K.R., Miller, R.G., Steinman, L. and Blau, H.M. (1992) Normal dystrophin transcripts detected in Duchenne muscular dystrophy patients after myoblast transplantation. Nature, 356, 435-438.
28. Mendell, J.R., Kissel, J.T., Amato, A.A., King, W., Signore, L., Prior, T.W., Sahenk, Z., Besson, S., McAndrew, P.E., Rice, R., Nagaraja, H., Stephens, R., Lantry, L., Morris, G.E. and Burghes, A.H.M. (1995) Myoblast transfer in the treatment of Duchenne's muscular dystrophy. N. Engl. J. Med., 333, 832-838.
29. Dunckley, M.G., Wells, D.J., Walsh, F.S. and Dickson, G. (1993) Direct retroviral-mediated transfer of a dystrophin minigene into mdx mouse muscle in vivo. Hum. Mol. Genet., 2, 717-723.
30. Grable, M. and Hearing, P. (1990) Adenovirus type 5 packaging domain is composed of a repeated element that is functionally redundant. J. Virol., 64, 2047-2056.
31. Grable, M. and Hearing, P (1992) cis and trans requirements for the selective packaging of adenovirus type 5 DNA. J. Virol., 66, 723-731.
32. Hay, R.T., Stow, N.D. and McDougall, I.M. (1984) Replication of adenovirus mini-chromosomes. J. Mol. Biol., 175, 493-510.
33. Mitani, K., Graham, F.L., Caskey, C.T. and Kochanek, S. (1995) Rescue, propagation, and partial purification of a helper virus-dependent adenovirus vector. Proc. Natl Acad. Sci. USA, 92, 3854-3858.
34. Chamberlain, J.S., Jaynes, J.B. and Hauschka, S.D. (1985) Regulation of creatine kinase induction in differentiating mouse myoblasts. Mol. Cell. Biol., 5, 484-492.
35. Jaynes, J.B., Chamberlain, J.S., Buskin, J.N., Johnson, J.E. and Hauschka, S.D. (1986) Transcriptional regulation of the muscle creatine kinase gene and regulated expression in transfected mouse myoblasts. Mol. Cell. Biol., 6, 2855-2864.
36. Kochanek, S., Clemens, P.R., Mitani, K. and Caskey, C.T. (1996) A new adenoviral vector: replacement of all viral coding sequences with 28 kb of DNA independently expressing both full-length dystrophin and β-galactosidase. Proc. Natl Acad. Sci. USA, in press.
37. Reich, M. and Zarybnicky, V. (1979) Rapid evaluation of the initial and equilibrium parameters of CsCl and RbCl in equilibrium ultracentrifugation. Anal. Biochem., 94, 193-201.
38. Yeh, P., Dedieu, J.F., Orsini, C., Vigne, E., Denefle, P. and Perricaudet, M. (1996) Efficient dual transcomplementation of adenovirus E1 and E4 regions from a 293-derived cell line expressing a minimal E4 functional unit. J. Virol., 70, 559-565.
39. Brough, D.E., Cleghon, V. and Klessig, D.F. (1992) Construction, characterization, and utilization of cell lines which inducibly express the adenovirus DNA-binding protein. Virology, 190, 624-634.
40. Amalfitano, A., Begy, C. and Chamberlain, J.S. (1996) Improved adenovirus packaging cell lines to support the growth of replication defective gene delivery vectors. Proc. Natl Acad. Sci. USA, 9, 3352-3356.
41. Imler, J.-L., Bout, A., Dreyer, D., Dieterlé, A., Schultz, H., Valerio, D., Mehtali, M. and Pavirani, A. (1995) Tram-complementation of El-deleted adenovirus: a new vector to reduce the possibility of codissemination of wild-type and recombinant adenoviruses. Hum. Gene Ther., 6, 711-721.
42. Sambrook, J., Fritsch, E.F. and Maniatis, T. (1989) Molecular Cloning: A Laboratory Manual. 2nd Edn. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
43. MacGregor, G.M. and Caskey, C.T. (1989) Construction of plasmids that express E.coli β-galactosidase in mammalian cells. Nucleic Acids Res., 17, 2365.
44. Anet, R. and Strayer, D.R. (1969) Density gradient relaxation: a method for preparative buoyant density separation of DNA. Biochem. Biophys. Res. Commun., 34, 328-334.
45. MacGregor, G.M., Nolan, G.P., Fiering, S., Roederer, M. and Herzenberg, L.A. (1991) Use of E.coli lacZ (β-galactosidase) as a reporter gene. In Murray, E. (ed),. Methods in Molecular Biology, Vol. 7: Gene Transfer and Expression Protocols. Human Press Inc., Clifton, NJ, pp. 217-225.
46. Linkhart, T.A., Clegg, C.H. and Hauschka, S.D. (1981) Myogenic differentiation in permanent clonal mouse myoblast cell lines: regulation by macromolecular growth factors in the culture medium. Dev. Biol., 86, 19-30.
47. Clegg, C.H., Linkhart, T.A., Olwin, B.B. and Hauschka, S.D. (1987) Growth factor control of skeletal muscle differentiation: commitment to terminal differentiation occurs in G1 phase and is repressed by fibroblast growth factor. J. Cell. Biol., 105, 949-956.